Obi Umeh, MD, MSc, VP, Franchise Global Program Leader at Takeda, discusses interim results from a study investigating mezagitamab for the treatment of patients with IgA nephropathy. This…
Dana Rizk, MD, professor of medicine at the University of Alabama at Birmingham, discusses the approval of Fabhalta (iptacopan) for adults with IgA nephropathy. Iptacopan, a Factor B…
NEW YORK (Reuters Health) – Percutaneous intervention may not be necessary for the majority of hypertensive patients with atherosclerotic renovascular disease. In a large retrospective study, researchers from…
NEW YORK (Reuters Health) – Coronary angiography is a recommended screening test for many patients undergoing kidney transplantation and now new research shows that it can be performed…
NEW YORK (Reuters Health) – In patients with mild renal insufficiency, a single IV bolus of sodium bicarbonate can help prevent contrast-induced nephropathy (CIN) during percutaneous coronary intervention…
NEW YORK (Reuters Health) – In non-diabetic patients with hypertensive kidney disease, the risk of hyperkalemia with angiotensin converting enzyme (ACE) inhibitors is “small,” according to research reported…
NEW YORK (Reuters Health) – High-dose N-acetylcysteine decreases the incidence of contrast-induced nephropathy, results of a meta-analysis indicate. “N-acetylcysteine has the advantages of being relatively innocuous, inexpensive, and…
NEW YORK (Reuters Health) – Giving low-dose dopamine to brain-dead donors can improve graft function after kidney transplantation, according to trial findings reported in the Journal of the…
NEW YORK (Reuters Health) – As a treatment for renal tumors, robot-assisted partial nephrectomy (RAPN) offers comparable oncologic control as traditional laparoscopic nephrectomy, but with less blood loss,…
Jaime Landman MD, Director of Minimally Invasive Urology at Columbia University Medical Center, describes the next step after minimally invasive laparascopic partial nephrectomy in the treatment of renal…
NEW YORK (Reuters Health) – A meta-analysis of trial data suggests that erythropoietin can be safely used to treat anemia in patients with chronic heart failure and may…
NEW YORK (Reuters Health) – Even when patients with type 1 diabetes have excellent hemoglobin A1C levels, continuous glucose monitoring will be beneficial, according to a report in…
